Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuzo Urata

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cell Structure and Function|November 16, 2020
An Antiviral Drug Screening Platform with a FRET Biosensor for Measurement of Arenavirus Z AssemblyTatsuaki Mizutani, Yusuke Ohba, Satoshi Mizuta, et al.
Journal of Virology|March 31, 2006
Cellular factors required for Lassa virus buddingShuzo Urata, Takeshi Noda, Yoshihiro Kawaoka, et al.
Viruses|July 2, 2021
The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2Mya Myat Ngwe Tun, Kouichi Morita, Takeshi Ishikawa, et al.
Virus Research|January 6, 2026
Identification of novel small chemical compounds that inhibit Ebola virus VP40-mediated virus-like particle productionTomoko Tsuruta, Satoshi Mizuta, Ayako Izumisawa, et al.
Antiviral Research|March 12, 2022
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virusMinato Hirano, Yasuteru Sakurai, Shuzo Urata, et al.
Japanese Journal of Infectious Diseases|March 1, 2026
Establishment of Training for Effective Decontamination of Positive-Pressure Protective Suits by Chemical ShowerYoshimi Tsuda, Misako Yajima, Shuzo Urata, et al.
Viruses|January 21, 2023
Topoisomerase II as a Novel Antiviral Target against Panarenaviral DiseasesTosin Oladipo Afowowe, Yasuteru Sakurai, Shuzo Urata, et al.
Journal of Virology|February 16, 2007
Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GPShuzo Urata, Takeshi Noda, Yoshihiro Kawaoka, et al.
Microbiology and Immunology|January 5, 2023
The roles of BST-2 in murine B cell development and on virus propagationShuzo Urata, Sachiko Yamaguchi, Aya Nambu, et al.
Plos Pathogens|July 11, 2022
Potential and action mechanism of favipiravir as an antiviral against Junin virusVahid Rajabali Zadeh, Tosin Oladipo Afowowe, Haruka Abe, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cell Structure and Function|November 16, 2020
An Antiviral Drug Screening Platform with a FRET Biosensor for Measurement of Arenavirus Z AssemblyTatsuaki Mizutani, Yusuke Ohba, Satoshi Mizuta, et al.
Journal of Virology|March 31, 2006
Cellular factors required for Lassa virus buddingShuzo Urata, Takeshi Noda, Yoshihiro Kawaoka, et al.
Viruses|July 2, 2021
The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2Mya Myat Ngwe Tun, Kouichi Morita, Takeshi Ishikawa, et al.
Virus Research|January 6, 2026
Identification of novel small chemical compounds that inhibit Ebola virus VP40-mediated virus-like particle productionTomoko Tsuruta, Satoshi Mizuta, Ayako Izumisawa, et al.
Antiviral Research|March 12, 2022
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virusMinato Hirano, Yasuteru Sakurai, Shuzo Urata, et al.
Japanese Journal of Infectious Diseases|March 1, 2026
Establishment of Training for Effective Decontamination of Positive-Pressure Protective Suits by Chemical ShowerYoshimi Tsuda, Misako Yajima, Shuzo Urata, et al.
Viruses|January 21, 2023
Topoisomerase II as a Novel Antiviral Target against Panarenaviral DiseasesTosin Oladipo Afowowe, Yasuteru Sakurai, Shuzo Urata, et al.
Journal of Virology|February 16, 2007
Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GPShuzo Urata, Takeshi Noda, Yoshihiro Kawaoka, et al.
Microbiology and Immunology|January 5, 2023
The roles of BST-2 in murine B cell development and on virus propagationShuzo Urata, Sachiko Yamaguchi, Aya Nambu, et al.
Plos Pathogens|July 11, 2022
Potential and action mechanism of favipiravir as an antiviral against Junin virusVahid Rajabali Zadeh, Tosin Oladipo Afowowe, Haruka Abe, et al.
Pageof 6